Delivery Order SPE2DB22D3010-SPE2DB25FP2UP

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verzenio 150 mg tablets, a medication used to treat certain types of breast cancer. The contract has a ceiling value of $16,229.44 and a performance period extending through May 13, 2025. This order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a $9,965.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Verzenio 50 mg tablets, a medication used to treat a certain type of breast cancer. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award, valued at $23,859.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Verzenio 100 mg tablets, a prescription medication used to treat breast cancer. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $17,909.02 contract is for the supply of the medication Verzenio 50 mg tablets, which is used to treat certain types of breast cancer. The award is not set aside for any specific business category. The contract has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corporation...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Verzenio 150 mg tablets, a medication used to treat certain types of breast cancer. The contract has a firm fixed price of $7,245.28 and a period of performance through June 27, 2025. The contract was awarded on June 26, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization and...
This federal contract award, valued at $7,245.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verzenio 150 mg tablets, a medication used for the treatment of certain types of breast cancer. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 19, 2024. It is not designated as a set-aside contract....
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,700.94, is for the delivery of Verzenio 150 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of July 29, 2024. This order is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,493.64, is for the delivery of Verzenio 100 mg tablets, a brand-name medication. The contract is a firm fixed-price delivery order, with a completion date of March 7, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verzenio 100 mg tablets, a pharmaceutical product used in healthcare. The contract has a ceiling value of $53,633.90 and a completion date of June 4, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a $9,118.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Verzenio 150 mg tablets, with a completion date of July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP2UP
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 mg Verzenio tablets, a medication used to treat breast cancer. The contract has a firm fixed price of $7,245.28 and a completion date of June 25, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 9/28/25, 1:53 AM